舌下神经刺激器植入三切口与两切口技术的非劣效性分析
本研究基于多中心回顾性与前瞻性注册研究,比较舌下神经刺激器植入的标准三切口(I3)与改良两切口(I2)技术。404例I3患者与223例I2患者中,I2手术时间从128.7分钟降至86.6分钟(P < .001)。匹配后76例I2与I3患者的呼吸暂停低通气指数变化达到非劣效(预设界值7.5事件/小时,平均差1.51,97.5%CI上限5.86)。两组基线特征、围手术期不良事件率和Epworth嗜睡评分变化无显著差异(P > .05)。
要点
- 两切口技术将呼吸传感导线移至第二肋间,消除第三胸部切口。
- 两切口组手术时间86.6分钟,显著短于三切口组128.7分钟(P < .001)。
- 匹配后呼吸暂停低通气指数变化达非劣效,不良事件率无显著差异(P > .05)。
核心结论
- 在多中心注册研究中,商用舌下神经刺激装置的两切口植入技术与标准三切口方法相比,疗效特征达到统计学非劣效。
- 两切口技术用于舌下神经刺激器植入安全有效。
研究设计与样本
- 非劣效性队列分析,基于回顾性与前瞻性注册研究。
- 设置:三级医疗和社区手术中心。
- 共6个参与中心,404例I3患者和223例I2患者。
- 既往标准三切口(I3)植入队列按1:1倾向性评分匹配,用于术后结局的非劣效性分析。
主要发现
- 手术时间从I3患者的128.7分钟(95%CI,124.5-132.9)降至I2患者的86.6分钟(95%CI,83.7-97.6)(P < .001)。
- 76例I2患者有术后睡眠研究数据并与I3患者匹配。
- 两队列间呼吸暂停低通气指数变化达到统计学非劣效(预设非劣效界值:7.5事件/小时;平均差1.51,97.5%CI上限5.86)。
- 两队列基线特征、围手术期不良事件率或Epworth嗜睡评分变化均无显著差异(P > .05)。
关键数值与推荐
- 非劣效界值:呼吸暂停低通气指数变化7.5事件/小时。
- 呼吸暂停低通气指数平均差1.51(97.5%CI上限5.86)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The only hypoglossal nerve stimulation (HNS) device available for US clinical use is implanted through 3 incisions. A recently proposed 2-incision modification moved the respiratory sensing lead from the fifth to the second intercostal space to eliminate the third lower chest incision. This study compared perioperative data and therapeutic outcomes between the techniques. STUDY DESIGN: Noninferiority cohort analysis of a retrospective and prospective registry study. SETTING: Tertiary care and community surgical centers. METHODS: Patients with obstructive sleep apnea underwent HNS implantation via a modified 2-incision technique (I2). A cohort previously implanted via the standard 3-incision technique (I3) were 1:1 propensity score matched for a noninferiority analysis of postoperative outcomes. RESULTS: There were 404 I3 patients and 223 I2 patients across 6 participating centers. Operative time decreased from 128.7 minutes (95% CI, 124.5-132.9) in I3 patients to 86.6 minutes (95% CI, 83.7-97.6) in I2 patients (P < .001). Postoperative sleep study data were available for 76 I2 patients who were matched to I3 patients. The change in apnea-hypopnea index between the cohorts was statistically noninferior (a priori noninferiority margin: 7.5 events/h; mean difference, 1.51 [97.5% CI upper bound, 5.86]). There were no significant differences between the cohorts for baseline characteristics, perioperative adverse event rates, or change in Epworth Sleepiness Score (P > .05). CONCLUSION: In a multicenter registry, a 2-incision implant technique for a commercially available HNS device had a statistically noninferior therapeutic efficacy profile when compared with the standard 3-incision approach. The 2-incision technique is safe and effective for HNS implantation.
引用
- Kent DT, Chio EG, Weiner JS, et al. A Noninferiority Analysis of 3- vs 2-Incision Techniques for Hypoglossal Nerve Stimulator Implantation. Otolaryngol Head Neck Surg. 2021. PMID: 34846979. doi:10.1177/01945998211062150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。